Cross-Border Bets and Delisting Clocks: Micro-Cap Biotech Fractures Under Liquidity SqueezeGlobal Report·2 days ago, 05:12 AMBIYA-1.66%ADTX+127.27%
TECOGEN INC. 2026: Revenue $5.75M, EPS ($0.07) — 10-Q SummaryTradingView·Aug 13 at 01:01 PMTGEN+4.91%VRT-1.01%
TGEN: Revenue fell 21% but backlog and data center traction signal growth aheadQuartr·Aug 13 at 10:06 AMTGEN+4.91%
Tecogen GAAP EPS of -$0.07 misses by $0.01, revenue of $5.75M misses by $1.55Mbusinessinsider·Aug 12 at 11:56 PMTGEN+4.91%
Tecogen: Buy Rating Reaffirmed as Data Center Pipeline Strengthens and $7.5 Price Target MaintainedTip Ranks·Aug 12 at 05:05 PMTGEN+4.91%
Tecogen | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 5.746 MEarnings Watch·Aug 12 at 04:47 PMTGEN+4.91%
Tecogen Q2 FY26 net loss widens 46.8% to $2.15 million; revenue falls 21.2% to $5.75 millionPUBT·Aug 12 at 03:57 PMTGEN+4.91%
Tecogen Reports Second Quarter 2026 Financial Results | TGEN Stock NewsStockTitan·Aug 12 at 08:00 AMTGEN+4.91%
Fringe Assets and Flawed Excuses: Stop Blaming AIGlobal Report·Aug 12 at 05:13 AMFVRR+0.33%TGEN+4.91%
Tecogen Schedules Earnings Release Date and Conference Call for Q2 2026 Results | TGEN Stock NewsStockTitan·Jul 31 at 07:45 AMTGEN+4.91%
Unbundling the Physical World: Value Chain Shifts from AI Infrastructure to Legacy AssetsGlobal Report·Jul 28 at 04:12 AMCBOE+2.25%NTAP-0.28%
